Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Smallpox

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.

Vaccinations

Vaccinations

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Immunogenicity and safety of MVA-BN vaccine administered 5 years after a two-dose primary series in DR Congo: a prospective cohort study.

The Lancet. Infectious diseases·2026

Same author

Safety of MVA-BN vaccine in health-care personnel in DR Congo: a prospective cohort study.

The Lancet. Infectious diseases·2026

Same author

COVID's origins: what we do and don't know.

Nature·2026

Same author

Vaccine and Treatment Evaluation Units: A Historical Perspective.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025

Same author

Clade II Mpox Infections Among Cruise Ship Passengers and Crew Members - United States, 2024.

MMWR. Morbidity and mortality weekly report·2025

Same author

Suspected and confirmed mpox cases in DR Congo: a retrospective analysis of national epidemiological and laboratory surveillance data, 2010-23.

Lancet (London, England)·2025

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Published on: September 8, 2023

Evaluation of smallpox vaccines using variola neutralization.

Inger K Damon¹, Whitni B Davidson¹, Christine M Hughes¹

¹Centers for Disease Control and Prevention, National Center for Zoonotic, Vector-borne, and Enteric Diseases, Division of Viral and Rickettsial Diseases, 1600 Clifton Road NE, Atlanta, GA 30333, USA.

The Journal of General Virology

|April 3, 2009

Summary

This summary is machine-generated.

A modified vaccinia Ankara vaccine candidate induces variola virus-neutralizing antibodies. This finding offers a method to assess vaccine efficacy against smallpox (variola virus) in the absence of challenge models.

More Related Videos

Optimization of a Quantitative Micro-neutralization Assay

Optimization of a Quantitative Micro-neutralization Assay

Published on: December 14, 2016

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Published on: November 21, 2023

Related Experiment Videos

Last Updated: Jun 24, 2026

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Published on: September 8, 2023

Optimization of a Quantitative Micro-neutralization Assay

Optimization of a Quantitative Micro-neutralization Assay

Published on: December 14, 2016

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Published on: November 21, 2023

Area of Science:

Virology
Immunology
Vaccinology

Background:

The development of third-generation smallpox vaccines is ongoing.
A key challenge is the lack of models to demonstrate protective immunity against variola virus.
In vitro virus neutralization assays are crucial for assessing vaccine activity.

Purpose of the Study:

To characterize the capacity of a modified vaccinia virus Ankara (MVA) vaccine to generate variola virus-neutralizing antibodies.
To compare the neutralization response induced by MVA with that of the standard Dryvax vaccine.

Main Methods:

Assessing the induction of variola virus-neutralizing antibodies by the MVA vaccine candidate.
Comparing the 'in vitro' neutralization activity of MVA-induced antibodies against Dryvax-induced antibodies.

Main Results:

The modified vaccinia virus Ankara vaccine candidate successfully induced variola virus-neutralizing antibodies.
The neutralization potency was compared to antibodies elicited by the standard Dryvax vaccine.

Conclusions:

Virus neutralization assays provide a valuable 'in vitro' method for evaluating smallpox vaccine candidates.
The MVA vaccine candidate demonstrates potential for inducing protective immune responses against variola virus.